logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Recode Therapeutics announced it raised $260 Million in an amended filing from an offering of $290 Million

Sep 28, 2023•about 2 years ago

Amount Raised

$260 Million

Menlo ParkBiotechnologyHealth Care

Company Information

Company

ReCode Therapeutics

Location

Menlo Park, California, United States

About

ReCode Therapeutics is a clinical-stage genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics. ReCode’s selective organ targeting (SORT) lipid nanoparticle (LNP) platform is a next-generation, genetic medicines technology that enables precise delivery to target organs and cells beyond the liver.

Related People

2 contacts

Sign in to view contact details

Sign in to view contact details

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech